MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers

[1]  Prashanth Rawla,et al.  Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma , 2023, Medical sciences.

[2]  Peter Thomson,et al.  Influence of time between surgery and adjuvant radiotherapy on prognosis for patients with head and neck squamous cell carcinoma: A systematic review , 2023, Head & neck.

[3]  Haijun Lu,et al.  New advances into cisplatin resistance in head and neck squamous carcinoma: Mechanisms and therapeutic aspects. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  Tongjun Gu,et al.  Investigating miR-9 as a mediator in laryngeal cancer health disparities , 2023, Frontiers in Oncology.

[5]  X. Cui,et al.  miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC , 2022, Cancers.

[6]  Yang Wang,et al.  GAS5 alleviates cisplatin drug resistance in oral squamous cell carcinoma by sponging miR-196a , 2022, The Journal of international medical research.

[7]  M. Libra,et al.  Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions , 2022, Non-coding RNA.

[8]  W. Deng,et al.  MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma , 2022, PloS one.

[9]  Zhiqing Hu,et al.  Selenium binding protein 1 inhibits tumor angiogenesis in colorectal cancers by blocking the Delta-like ligand 4/Notch1 signaling pathway , 2022, Translational oncology.

[10]  M. Moghbeli,et al.  Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview , 2022, Cancer Cell International.

[11]  Ling Gao,et al.  Circ-PKD2 promotes Atg13-mediated autophagy by inhibiting miR-646 to increase the sensitivity of cisplatin in oral squamous cell carcinomas , 2022, Cell death & disease.

[12]  Juan Chen,et al.  Circ_0005033 is an oncogene in laryngeal squamous cell carcinoma and regulates cell progression and Cisplatin sensitivity via miR-107/IGF1R axis , 2021, Anti-cancer drugs.

[13]  A. Amini,et al.  An Updated Review on Head and Neck Cancer Treatment with Radiation Therapy , 2021, Cancers.

[14]  M. Moghbeli.  MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells , 2021, Journal of Ovarian Research.

[15]  M. Moghbeli,et al.  Molecular mechanisms of the microRNA-132 during tumor progressions , 2021, Cancer Cell International.

[16]  M. Moghbeli,et al.  MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells , 2021, Genes and environment : the official journal of the Japanese Environmental Mutagen Society.

[17]  Hailin Zhang,et al.  The LncRNA FGD5‐AS1/miR‐497‐5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin‐resistance in laryngeal squamous cell carcinoma , 2021, Molecular carcinogenesis.

[18]  H. Zeng,et al.  Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1–NRF2 signaling , 2021, Cancer Chemotherapy and Pharmacology.

[19]  Yan Zhou,et al.  HOXA11-AS induces cisplatin resistance by modulating the microRNA-98/PBX3 axis in nasopharyngeal carcinoma , 2021, Oncology letters.

[20]  M. Moghbeli,et al.  MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells , 2021, Cancer cell international.

[21]  F. Yuan,et al.  Long non-coding RNA KCNQ1OT1 promotes nasopharyngeal carcinoma cell cisplatin resistance via the miR-454/USP47 axis , 2021, International journal of molecular medicine.

[22]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[23]  J. Zang,et al.  The miR-136-5p/ROCK1 axis suppresses invasion and migration, and enhances cisplatin sensitivity in head and neck cancer cells , 2021, Experimental and therapeutic medicine.

[24]  Junbo Zhou,et al.  Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma , 2021, International journal of biological sciences.

[25]  H. Qin,et al.  CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma , 2021, Drug design, development and therapy.

[26]  Xinru Kong,et al.  H19/miR‐107/HMGB1 axis sensitizes laryngeal squamous cell carcinoma to cisplatin by suppressing autophagy in vitro and in vivo , 2020, Cell biology international.

[27]  Xuehan Yi,et al.  Circular RNA circ_0004507 contributes to laryngeal cancer progression and cisplatin resistance by sponging miR‐873 to upregulate multidrug resistance 1 and multidrug resistance protein 1 , 2020, Head & neck.

[28]  Xiandong Lin,et al.  Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met , 2020, Molecules and cells.

[29]  Bo Feng,et al.  circPGAM1 enhances autophagy signaling during laryngocarcinoma drug resistance by regulating miR-376a. , 2020, Biochemical and biophysical research communications.

[30]  Yurong Song,et al.  PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers , 2020, Cell Death & Disease.

[31]  M. Schaalan,et al.  Implications of miRNAs on TGF-β/TAK1/mTOR pathway in mediating the renoprotective effects of pentoxifylline against cisplatin-induced nephrotoxicity in rats. , 2020, Toxicology and applied pharmacology.

[32]  Fei Gao,et al.  Circ_0109291 Promotes the Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188-3p to Increase ABCB1 Expression. , 2020, Cancer biotherapy & radiopharmaceuticals.

[33]  Xiaolong Wang,et al.  ZFAS1 Promotes Cisplatin Resistance via Suppressing miR-421 Expression in Oral Squamous Cell Carcinoma , 2020, Cancer management and research.

[34]  Rong Wang,et al.  Leptin promotes endothelial dysfunction in chronic kidney disease by modulating the MTA1-mediated WNT/β-catenin pathway , 2020, Molecular and Cellular Biochemistry.

[35]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[36]  Cheng Cao,et al.  Long noncoding RNA MAGI2‐AS3/miR‐218‐5p/GDPD5/SEC61A1 axis drives cellular proliferation and migration and confers cisplatin resistance in nasopharyngeal carcinoma , 2020, International forum of allergy & rhinology.

[37]  Yingying Zhao,et al.  miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B. , 2020, Molecular and cellular probes.

[38]  A. Aupérin.  Epidemiology of head and neck cancers: an update. , 2020, Current opinion in oncology.

[39]  Yue Wu,et al.  A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer. , 2020, Experimental cell research.

[40]  Yunpeng Bai,et al.  The Role of Carcinogenesis-Related Biomarkers in the Wnt Pathway and Their Effects on Epithelial–Mesenchymal Transition (EMT) in Oral Squamous Cell Carcinoma , 2020, Cancers.

[41]  Hui Liu,et al.  miR-936 Suppresses Cell Proliferation, Invasion, and Drug Resistance of Laryngeal Squamous Cell Carcinoma and Targets GPR78 , 2020, Frontiers in Oncology.

[42]  Zhangguo Chen,et al.  Tumor immune microenvironment in head and neck cancers , 2020, Molecular carcinogenesis.

[43]  M. Mojarrad,et al.  Long non-coding RNAs as the critical factors during tumor progressions among Iranian population: an overview , 2020, Cell & Bioscience.

[44]  Yanshan Liu,et al.  MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1 , 2020, Bioengineered.

[45]  Zhihua Liu,et al.  ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4. , 2019, Cancer letters.

[46]  Daming Liu,et al.  Long noncoding RNA LINC‐PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR‐425‐5p/PTCH1/SHH axis , 2019, Journal of cellular physiology.

[47]  D. Kallogjeri,et al.  Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer. , 2019, JAMA otolaryngology-- head & neck surgery.

[48]  R. Ge,et al.  Cell Surface GRP78 as a Death Receptor and an Anticancer Drug Target , 2019, Cancers.

[49]  S. Tsao,et al.  MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma , 2019, BMC Cancer.

[50]  E. Babin,et al.  Platinum rechallenge in recurrent head and neck squamous cell carcinoma after primary chemoradiation. , 2019, European annals of otorhinolaryngology, head and neck diseases.

[51]  Surong Zhao,et al.  miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells. , 2019, Gene.

[52]  A. Goldberg,et al.  SIP/CacyBP promotes autophagy by regulating levels of BRUCE/Apollon, which stimulates LC3-I degradation , 2019, Proceedings of the National Academy of Sciences.

[53]  Yingqin Li,et al.  Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma. , 2019, The New England journal of medicine.

[54]  Hong Li,et al.  LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression , 2019, BioMed research international.

[55]  Chao Wu,et al.  IL‐25 promotes cisplatin resistance of lung cancer cells by activating NF‐κB signaling pathway to increase of major vault protein , 2019, Cancer medicine.

[56]  M. Abbaszadegan,et al.  Role of MAML1 in targeted therapy against the esophageal cancer stem cells , 2019, Journal of Translational Medicine.

[57]  N. Agrawal,et al.  The role of tumor DNA as a diagnostic tool for head and neck squamous cell carcinoma. , 2019, Seminars in cancer biology.

[58]  Hongfang Li,et al.  By downregulating PBX3, miR-526b suppresses the epithelial-mesenchymal transition process in cervical cancer cells. , 2019, Future oncology.

[59]  Zhi Yang,et al.  Zinc finger antisense 1: A long noncoding RNA with complex roles in human cancers. , 2019, Gene.

[60]  Shi-Long Lu,et al.  The Role of MicroRNAs in Recurrence and Metastasis of Head and Neck Squamous Cell Carcinoma , 2019, Cancers.

[61]  K. Prabhash,et al.  Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer , 2019, Frontiers in Oncology.

[62]  Xu Wang,et al.  Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5 , 2019, Genome Biology.

[63]  M. Abbaszadegan,et al.  ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer , 2019, Biological Research.

[64]  Xia Gao,et al.  TIMP-3 Increases the Chemosensitivity of Laryngeal Carcinoma to Cisplatin via Facilitating Mitochondria-Dependent Apoptosis. , 2018, Oncology research.

[65]  J. Fayette,et al.  Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Question of Belief , 2018, Cancers.

[66]  G. de Castro,et al.  Criteria for eligibility to cisplatin in the curative treatment of head and neck cancer: Consensus opinion from a panel of experts. , 2018, Critical reviews in oncology/hematology.

[67]  A. Diamond,et al.  Selenium-Binding Protein 1 in Human Health and Disease , 2018, International journal of molecular sciences.

[68]  Yingying Zhang,et al.  TGF-β1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2/3 signalling pathway , 2018, International journal of molecular medicine.

[69]  B. Solomon,et al.  Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments. , 2018, Seminars in cancer biology.

[70]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[71]  C. Caux,et al.  MDR1 in immunity: friend or foe? , 2018, Oncoimmunology.

[72]  Su Wang,et al.  Identification and expression of carbonic anhydrase 2, myosin regulatory light chain 2 and selenium-binding protein 1 in zebrafish Danio rerio: Implication for age-related biomarkers. , 2018, Gene expression patterns : GEP.

[73]  C. Menck,et al.  DNA repair pathways and cisplatin resistance: an intimate relationship , 2018, Clinics.

[74]  R. Amaravadi,et al.  Targeting autophagy in cancer , 2018, Cancer.

[75]  Yongyong Xie,et al.  MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[76]  Xinchen Sun,et al.  High‐mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma , 2018, Journal of gastroenterology and hepatology.

[77]  Hao Liu,et al.  miR-22/KAT6B axis is a chemotherapeutic determiner via regulation of PI3k-Akt-NF-kB pathway in tongue squamous cell carcinoma , 2018, Journal of experimental & clinical cancer research : CR.

[78]  R. Pei,et al.  Long non‐coding RNA AFAP1‐AS1/miR‐320a/RBPJ axis regulates laryngeal carcinoma cell stemness and chemoresistance , 2018, Journal of cellular and molecular medicine.

[79]  Daming Zhang,et al.  LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling , 2018, Cell Death & Disease.

[80]  Jayshree Advani,et al.  Cigarette smoke and chewing tobacco alter expression of different sets of miRNAs in oral keratinocytes , 2018, Scientific Reports.

[81]  T. Tan,et al.  Dual role of autophagy in hallmarks of cancer , 2018, Oncogene.

[82]  I. Berindan‐Neagoe,et al.  The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression , 2018, Cell Death & Disease.

[83]  Julia C. Engelmann,et al.  Selenium-binding protein 1 is down-regulated in malignant melanoma , 2018, Oncotarget.

[84]  Ming Yan,et al.  Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway , 2018, Theranostics.

[85]  Y. Surh,et al.  Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of Snail: A potential role of Sox9 , 2017, Scientific Reports.

[86]  Qiang Sun,et al.  LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR‐184 expression , 2017, Cancer medicine.

[87]  Ming Liu,et al.  Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2 , 2017, Oncotarget.

[88]  Xiaodong Li,et al.  Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma , 2017, Acta biochimica et biophysica Sinica.

[89]  Xiqiang Liu,et al.  MicroRNA-218 promotes cisplatin resistance in oral cancer via the PPP2R5A/Wnt signaling pathway , 2017, Oncology reports.

[90]  A. Thorburn,et al.  Targeting autophagy in cancer , 2017, Nature Reviews Cancer.

[91]  T. Cheng,et al.  PBX3 is essential for leukemia stem cell maintenance in MLL‐rearranged leukemia , 2017, International journal of cancer.

[92]  Yandan Wang,et al.  Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin‐induced cytotoxicity via regulating microRNA let‐7a in nasopharyngeal carcinoma , 2017, Journal of biochemical and molecular toxicology.

[93]  Guanghui Wang,et al.  MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[94]  Hongmei Guo,et al.  miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer. , 2017, Oncology reports.

[95]  Yin Liang,et al.  microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2. , 2017, Molecular medicine reports.

[96]  M. Abbaszadegan,et al.  TWIST1 upregulates the MAGEA4 oncogene , 2017, Molecular carcinogenesis.

[97]  Q. Fu,et al.  miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin , 2017, Oncogene.

[98]  M. Cecchini,et al.  Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease , 2016, Scientific Reports.

[99]  Shisheng Li,et al.  Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells , 2016, Oncotarget.

[100]  C. Xing,et al.  PBX3 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition , 2016, Oncology letters.

[101]  Zhiyu Zhang,et al.  Down‐regulation of miR‐26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1 , 2016, FEBS open bio.

[102]  J. Utikal,et al.  TGF‐β induces SOX2 expression in a time‐dependent manner in human melanoma cells , 2016, Pigment cell & melanoma research.

[103]  N. Johnson,et al.  Global Epidemiology of Head and Neck Cancers: A Continuing Challenge , 2016, Oncology.

[104]  Peng Shang,et al.  miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer. , 2016, Biochemical and biophysical research communications.

[105]  Yongli Guo,et al.  MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma. , 2016, Oncology reports.

[106]  W. G. Wiles,et al.  SOX4 Is Essential for Prostate Tumorigenesis Initiated by PTEN Ablation. , 2016, Cancer research.

[107]  M. Kahn,et al.  The Wnt signaling pathway in cancer. , 2016, Critical reviews in oncology/hematology.

[108]  N. Wlodarchak,et al.  PP2A as a master regulator of the cell cycle , 2016, Critical reviews in biochemistry and molecular biology.

[109]  Ming Yan,et al.  TGFβ3-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis , 2016, Scientific Reports.

[110]  M. Solas,et al.  c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease , 2016, Front. Pharmacol..

[111]  Y. Joo,et al.  SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma , 2015, BMC Cancer.

[112]  Chunyan Ma,et al.  HAX-1 inhibits apoptosis in prostate cancer through the suppression of caspase-9 activation. , 2015, Oncology reports.

[113]  X. Zhang,et al.  SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2 , 2015, Cell Death and Disease.

[114]  Xiangqian Zheng,et al.  MicroRNA-24 induces cisplatin resistance by targeting PTEN in human tongue squamous cell carcinoma. , 2015, Oral oncology.

[115]  S. Patrick,et al.  Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links. , 2015, DNA repair.

[116]  Yang Liu,et al.  HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2 , 2015, Tumor Biology.

[117]  Y. You,et al.  MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1α in nasopharyngeal carcinoma. , 2015, Oncology reports.

[118]  A. Kaufmann,et al.  MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro. , 2015, International journal of oncology.

[119]  Zhi-jian Liu,et al.  MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1. , 2015, American journal of cancer research.

[120]  Ziyi Zhao,et al.  Has‑miR‑125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53‑dependent manner by targeting p53 mRNA. , 2015, Molecular medicine reports.

[121]  Lu Zhang,et al.  FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition. , 2015, Cancer letters.

[122]  Xiaobin Lv,et al.  miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1. , 2015, Cancer letters.

[123]  Jianping Zhang,et al.  MicroRNA‐191, by promoting the EMT and increasing CSC‐like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells , 2015, Molecular carcinogenesis.

[124]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[125]  Elaine Fuchs,et al.  TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma , 2015, Cell.

[126]  Ping-qing Tan,et al.  miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist. , 2015, Oncology reports.

[127]  R. Weichselbaum,et al.  MUC1-C ACTIVATES THE TAK1 INFLAMMATORY PATHWAY IN COLON CANCER , 2015, Oncogene.

[128]  Yuhan Chen,et al.  Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients’ prognosis , 2014, Medical Oncology.

[129]  P. Tchounwou,et al.  Cisplatin in cancer therapy: molecular mechanisms of action. , 2014, European journal of pharmacology.

[130]  Renato Martins,et al.  Head and Neck Cancers, Version 2.2014 , 2014 .

[131]  Prashant Mishra,et al.  Mitochondrial dynamics and inheritance during cell division, development and disease , 2014, Nature Reviews Molecular Cell Biology.

[132]  B. Fadeel,et al.  Exploring the anti‐apoptotic role of HAX‐1 versus BCL‐XL in cytokine‐dependent bone marrow‐derived cells from mice , 2014, FEBS letters.

[133]  T. Ng,et al.  Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia. , 2014, Biochemical pharmacology.

[134]  A. Thorburn,et al.  Autophagy and Cancer Therapy , 2014, Molecular Pharmacology.

[135]  Kyoung-Jae Won,et al.  RBPJ, the Major Transcriptional Effector of Notch Signaling, Remains Associated with Chromatin throughout Mitosis, Suggesting a Role in Mitotic Bookmarking , 2014, PLoS genetics.

[136]  F. Bunz,et al.  A loss-of-function mutation in PTCH1 suggests a role for autocrine hedgehog signaling in colorectal tumorigenesis , 2013, Oncotarget.

[137]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2013, Nature Medicine.

[138]  Huiling Yang,et al.  Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma , 2013, Cell Death and Disease.

[139]  B. Van Houten,et al.  The role of dynamin-related protein 1 in cancer growth: a promising therapeutic target? , 2013, Expert opinion on therapeutic targets.

[140]  B. Berghuis,et al.  MET and ERBB2 Are Coexpressed in ERBB2+ Breast Cancer and Contribute to Innate Resistance , 2013, Molecular Cancer Research.

[141]  Piotr J. Balwierz,et al.  Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. , 2013, Cancer cell.

[142]  H. Stunnenberg,et al.  Dynamic binding of RBPJ is determined by Notch signaling status. , 2013, Genes & development.

[143]  M. Ringnér,et al.  Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development , 2013, Proceedings of the National Academy of Sciences.

[144]  Reddanna Pallu,et al.  Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells , 2013, Front. Oncol..

[145]  Li‐jun Wu,et al.  Silence of ezrin modifies migration and actin cytoskeleton rearrangements and enhances chemosensitivity of lung cancer cells in vitro , 2013, Molecular and Cellular Biochemistry.

[146]  Y. Hu,et al.  Activated ERM Protein Plays a Critical Role in Drug Resistance of MOLT4 Cells Induced by CCL25 , 2013, PloS one.

[147]  A. Goel,et al.  Epigenetic mechanisms in oral carcinogenesis. , 2012, Future oncology.

[148]  Amy Y. Chen,et al.  Adenoid cystic carcinoma of the head and neck , 2012, Cancer.

[149]  Yu Zhang,et al.  SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. , 2012, Cancer research.

[150]  D. Klionsky,et al.  Receptor protein complexes are in control of autophagy , 2012, Autophagy.

[151]  G. Wong,et al.  Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma* , 2012, The Journal of Biological Chemistry.

[152]  J. Massagué,et al.  TGF‐β control of stem cell differentiation genes , 2012, FEBS letters.

[153]  L. Siu,et al.  A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[154]  L. Galluzzi,et al.  Molecular mechanisms of cisplatin resistance , 2012, Oncogene.

[155]  J. Li,et al.  MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1 , 2012, Oncogene.

[156]  K. Miyazono,et al.  Glioma-initiating Cells Retain Their Tumorigenicity through Integration of the Sox Axis and Oct4 Protein* , 2011, The Journal of Biological Chemistry.

[157]  Shengbing Huang,et al.  The Role of Autophagy in Cancer: Therapeutic Implications , 2011, Molecular Cancer Therapeutics.

[158]  Chi-Tang Ho,et al.  Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells. , 2011, Journal of agricultural and food chemistry.

[159]  Ann E. Frazier,et al.  MiD49 and MiD51, new components of the mitochondrial fission machinery , 2011, EMBO reports.

[160]  A. Ho,et al.  Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. , 2011, The Lancet. Oncology.

[161]  Yibin Kang,et al.  Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. , 2011, Cancer cell.

[162]  Zhiwei Wang,et al.  Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. , 2010, Biochimica et biophysica acta.

[163]  Chi-Hung Huang,et al.  Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition , 2010, Nature Cell Biology.

[164]  M. Todaro,et al.  Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. , 2010, Cancer research.

[165]  Y. Miki,et al.  Pim-1 controls NF-κB signalling by stabilizing RelA/p65 , 2010, Cell Death and Differentiation.

[166]  J. Siedlecki,et al.  HAX-1 overexpression, splicing and cellular localization in tumors , 2010, BMC Cancer.

[167]  Wenlin Huang,et al.  The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. , 2009, The Journal of clinical investigation.

[168]  P. Fortina,et al.  p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo , 2009, Proceedings of the National Academy of Sciences.

[169]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[170]  Z. Dong,et al.  Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. , 2009, The Journal of clinical investigation.

[171]  Anindya Dutta,et al.  MicroRNAs in cancer. , 2009, Annual review of pathology.

[172]  S. Narumiya,et al.  Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion , 2009, Cancer and Metastasis Reviews.

[173]  R. Youle,et al.  Mitochondrial dynamics and apoptosis. , 2008, Genes & development.

[174]  H. Nagatsuka,et al.  The inhibitor of growth (ING) gene family: potential role in cancer therapy. , 2008, Current cancer drug targets.

[175]  Stella Logotheti,et al.  The role of ATF‐2 in oncogenesis , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[176]  J. Nishikawa,et al.  Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK and induces tumour marker gene expression during hepatocarcinogenesis. , 2007, The Biochemical journal.

[177]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[178]  S. Hammond.  RNAi, microRNAs, and human disease , 2006, Cancer Chemotherapy and Pharmacology.

[179]  S. Dei,et al.  The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR). , 2006, Current drug targets.

[180]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[181]  A. Krämer,et al.  Human splicing factor SF3a, but not SF1, is essential for pre-mRNA splicing in vivo. , 2005, Molecular biology of the cell.

[182]  R. Youle,et al.  Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. , 2004, Molecular biology of the cell.

[183]  V. Velculescu,et al.  Oncogenic Mutations of PIK3CA in Human Cancers , 2004, Cell cycle.

[184]  D. Mercola,et al.  The Activation of c-Jun NH2-terminal Kinase (JNK) by DNA-damaging Agents Serves to Promote Drug Resistance via Activating Transcription Factor 2 (ATF2)-dependent Enhanced DNA Repair* , 2003, Journal of Biological Chemistry.

[185]  Anne J. Ridley,et al.  ROCKs: multifunctional kinases in cell behaviour , 2003, Nature Reviews Molecular Cell Biology.

[186]  M. Murakami,et al.  The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells , 2003, Cell.

[187]  S. Hayward,et al.  Nuclear Localization of CBF1 Is Regulated by Interactions with the SMRT Corepressor Complex , 2001, Molecular and Cellular Biology.

[188]  A. Spicer,et al.  Hyaluronan: a multifunctional, megaDalton, stealth molecule. , 2000, Current opinion in cell biology.

[189]  M. Waye,et al.  Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding protein , 1997 .

[190]  B. Dérijard,et al.  Transcription factor ATF2 regulation by the JNK signal transduction pathway , 1995, Science.

[191]  C. Underhill,et al.  CD44: the hyaluronan receptor. , 1992, Journal of cell science.

[192]  Junan Li,et al.  MicroRNA-205 targets HER3 and suppresses the growth, chemosensitivity and metastasis of human nasopharyngeal carcinoma cells. , 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[193]  J. Shah,et al.  Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[194]  R. Bhargava,et al.  The role of human papillomavirus in nongenital cancers , 2013, CA: a cancer journal for clinicians.

[195]  M. Nawijn,et al.  For better or for worse: the role of Pim oncogenes in tumorigenesis , 2011, Nature Reviews Cancer.

[196]  Z. Ronai,et al.  Emerging roles of ATF2 and the dynamic AP1 network in cancer , 2010, Nature Reviews Cancer.

[197]  M. Karin,et al.  Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. , 2009 .

[198]  Michael Karin,et al.  Is NF-κB a good target for cancer therapy? Hopes and pitfalls , 2009, Nature Reviews Drug Discovery.

[199]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[200]  H. Moses,et al.  Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. , 2001, Molecular biology of the cell.

[201]  M. Waye,et al.  Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding protein. , 1997, Journal of cellular biochemistry.

[202]  S. Taylor.  Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.